Literature DB >> 10024203

Toxic oil syndrome mortality: the first 13 years.

I Abaitua Borda1, R M Philen, M Posada de la Paz, A Gómez de la Cámara, M Díez Ruiz-Navarro, O Giménez Ribota, J Alvargonzález Soldevilla, B Terracini, S Severiano Peña, C Fuentes Leal, E M Kilbourne.   

Abstract

BACKGROUND: The toxic oil syndrome (TOS) epidemic that occurred in Spain in the spring of 1981 caused approximately 20000 cases of a new illness. Overall mortality and mortality by cause in this cohort through 1994 are described for the first time in this report.
METHODS: We contacted, via mail or telephone, almost every living member of the cohort and family members of those who were known to have died in order to identify all deaths from 1 May 1981 through 31 December 1994. Cause of death data were collected from death certificates and underlying causes of death were coded using the International Classification of Diseases, 9th Revision.
RESULTS: We identified 1663 deaths between 1 May 1981 and 31 December 1994 among 19 754 TOS cohort members, for a crude mortality rate of 8.4%. Mortality was highest during 1981, with a standardized mortality ratio (SMR) of 4.92 (95% confidence interval [CI]: 4.39-5.50) compared with the Spanish population as a whole. The highest SMR, (20.41, 95% CI: 15.97-25.71) was seen among women aged 20-39 years during the period from 1 May 1981 through 31 December 1982. Women <40 years old, who were affected by TOS , were at greater risk for death in most time periods than their unaffected peers, while older women and men were not. Over the follow-up period, mortality of the cohort was less than expected when compared with mortality of the general Spanish population, or with mortality of the population of the 14 provinces where the epidemic occurred. We also found that, except for deaths attributed to external causes including TOS and deaths due to pulmonary hypertension, all causes of death were decreased in TOS patients compared to the Spanish population. The most frequent underlying causes of death were TOS, 350 (21.1%); circulatory disorders, 536 (32.3%); and malignancies, 310 (18.7%).
CONCLUSIONS: We conclude that while on average people affected by toxic oil syndrome are not at greater risk for death over the 13-year study period than any of the comparison groups, women <40 years old were at greater risk of death.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10024203     DOI: 10.1093/ije/27.6.1057

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  4 in total

1.  The impact of toxic oil syndrome on physical and psychological health status using the HAQ and the PHQ-9 questionnaires.

Authors:  Macarena Garrido-Estepa; Greta Arias-Merino; Verónica Alonso-Ferreira; Ana Villaverde-Hueso; Manuel Posada de la Paz
Journal:  Qual Life Res       Date:  2022-06-02       Impact factor: 3.440

Review 2.  The Spanish toxic oil syndrome 20 years after its onset: a multidisciplinary review of scientific knowledge.

Authors:  Emilio Gelpí; Manuel Posada de la Paz; Benedetto Terracini; Ignacio Abaitua; Agustín Gómez de la Cámara; Edwin M Kilbourne; Carlos Lahoz; Bénoit Nemery; Rossanne M Philen; Luis Soldevilla; Stanislaw Tarkowski
Journal:  Environ Health Perspect       Date:  2002-05       Impact factor: 9.031

3.  Pharmacogenetic profile of xenobiotic enzyme metabolism in survivors of the Spanish toxic oil syndrome.

Authors:  M G Ladona; M Izquierdo-Martinez; M P Posada de la Paz; R de la Torre; C Ampurdanés; J Segura; E J Sanz
Journal:  Environ Health Perspect       Date:  2001-04       Impact factor: 9.031

4.  Neurologic outcomes of toxic oil syndrome patients 18 years after the epidemic.

Authors:  Manuel Posada de la Paz; Rossanne M Philen; Fredric Gerr; Richard Letz; Maria José Ferrari Arroyo; Lydia Vela; Maravillas Izquierdo; Concepción Martín Arribas; Ignacio Abaitua Borda; Alejandro Ramos; Cristina Mora; Gloria Matesanz; Maria Teresa Roldán; Juan Pareja
Journal:  Environ Health Perspect       Date:  2003-08       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.